Overview: C-Peptide Postprandial TestIntroduction: The C-Peptide Postprandial Test measures C-peptide after meals to assess insulin production, helping diagnose diabetes or hypoglycemia. Following 2023 ADA guidelines, it uses an immunoassay for high sensitivity, aiding in endocrine screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in endocrinology for patients with suspected metabolic disorders.
Other Names: C-Peptide PP Assay, Insulin Production Test.
FDA Status: Laboratory-developed test (LDT), meeting endocrinology standards for diagnostic accuracy.
Historical Milestone: C-peptide testing began in the 1970s with diabetes research. Postprandial assays emerged in the 1980s, and by the 2000s, high-sensitivity immunoassays improved accuracy.
Purpose: Diagnoses diabetes or hypoglycemia, guides treatment, and monitors postprandial C-peptide levels in patients with fatigue or shakiness.
Test Parameters: 1. C-Peptide
Pretest Condition: Fasting for 10-12 hours required, followed by a meal. Collect serum or plasma 2 hours post-meal. Report symptoms like fatigue or shakiness, and list medications like insulin.
Specimen: 2-5 mL serum (SST) or 2-4 mL plasma (EDTA). Centrifuge within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fatigue, shakiness, or history of diabetes/hypoglycemia. Include current medications, especially insulin or oral hypoglycemics.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for diabetes or hypoglycemia treatment.
Procedural Considerations: Uses an immunoassay to measure postprandial C-peptide levels. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Improper meal timing or insulin therapy may alter results. Hemolysis or improper storage can degrade samples.
Clinical Significance: High postprandial C-peptide levels suggest insulin resistance, prompting lifestyle or medication changes. Low levels indicate insulin deficiency.
Specialist Consultation: Consult an endocrinologist for result interpretation. A diabetologist referral is advised for complex cases.
Additional Supporting Tests: Postprandial glucose test, HbA1c, or insulin level test to confirm diabetes or hypoglycemia.
Test Limitations: Results may be affected by meal composition or insulin therapy. Clinical correlation is required.
References: ADA Diabetes Guidelines, 2023; Diabetes Care, Skyler JS, 2022.
